FRA:BAYN - Bayer Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
€62.59 -4.05 (-6.08 %)
(As of 11/16/2018 04:00 PM ET)
Previous Close€66.64
Today's Range€61.66 - €63.87
52-Week Range€91.58 - €123.82
Volume5.44 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. Bayer Aktiengesellschaft has a collaboration agreement with The University of Texas MD Anderson Cancer Center to develop cancer treatments, as well as Haplogen GmbH. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange FRA
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolFRA:BAYN
Previous Symbol
CUSIPN/A
Phone+49-214-301

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees124,055
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Bayer (FRA:BAYN) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the FRA under the ticker symbol "BAYN."

What price target have analysts set for BAYN?

23 equities research analysts have issued 12-month price targets for Bayer's shares. Their predictions range from €70.00 to €125.00. On average, they expect Bayer's stock price to reach €94.61 in the next year. This suggests a possible upside of 51.2% from the stock's current price. View Analyst Price Targets for Bayer.

What is the consensus analysts' recommendation for Bayer?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 7 hold ratings and 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bayer.

Has Bayer been receiving favorable news coverage?

News stories about BAYN stock have been trending negative this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bayer earned a news impact score of -2.7 on InfoTrie's scale. They also gave news articles about the healthcare company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next few days.

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 56)
  • Mr. Liam Condon, CEO & Pres of Bayer Cropscience and Member of Management Board (Age 50)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 56)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 62)
  • Mr. Dieter Weinand, Head of the Pharmaceuticals Division & Member of Management Board (Age 58)

What is Bayer's stock price today?

One share of BAYN stock can currently be purchased for approximately €62.59.

What is Bayer's official website?

The official website for Bayer is https://www.bayer.de/.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.


MarketBeat Community Rating for Bayer (FRA BAYN)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  1,272 (Vote Outperform)
Underperform Votes:  828 (Vote Underperform)
Total Votes:  2,100
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/16/2018 by MarketBeat.com Staff

Featured Article: Intrinsic Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel